Item 4. | Purpose of Transaction |
Item 4 is hereby amended to add the following:
Underwriting Agreement
On November 7, 2022, the Reporting Person entered into an underwriting agreement (the “Underwriting Agreement”) with the Issuer and UBS Securities LLC and Goldman Sachs & Co. LLC, as the representatives of the several underwriters (the “Underwriters”), pursuant to which the Underwriters agreed to purchase 14,350,000 shares of Common Stock from the Reporting Person (the “Public Equity Offering”) with an option to purchase up to 1,627,500 additional shares of Common Stock from the Reporting Person (the “Option”), each at a price of $12.99375 per share. The Underwriters gave notice on November 8, 2022 to the Reporting Person of their intention to exercise the Option in full. The Public Equity Offering and the Option closed on November 10, 2022.
Simultaneously upon the closing of the Public Equity Offering, the Issuer repurchased 3,500,000 shares of its Common Stock from the Underwriters at a price per share equal to the price per share paid by the Underwriters to the Reporting Person in the Public Equity Offering and the Option.
Lock-up Agreement
In connection with the Underwriting Agreement, the Reporting Person entered into a 90-day lock-up agreement (the “Lock-up Agreement”) with the Underwriters.
The descriptions of the Underwriting Agreement and Lock-up Agreement are summaries only and are qualified in their entirety by reference to the texts of the Underwriting Agreement and Lock-up Agreement, which are referenced as Exhibit 1 and Exhibit 2 to this Statement. The Underwriting Agreement is incorporated by reference to Exhibit 1.1 to the Current Report on Form 8-K filed by the Issuer with the SEC on November 10, 2022.
Item 5. | Interest in Securities of the Issuer |
Sections (a), (b) and (c) of Item 5 are hereby amended and restated in their entirety as follows:
(a), (b) Based upon the Issuer’s Prospectus Supplement filed on November 7, 2022, there were 81,996,835 shares of Common Stock outstanding as of October 31, 2022. On November 10, 2022, the Reporting Person sold 14,350,000 shares of Common Stock in the Public Equity Offering and the Issuer repurchased 3,500,000 shares of its Common Stock. On November 10, 2022, the Reporting Person also sold 1,627,500 additional shares of Common Stock to the Underwriters pursuant to the exercise of the Option. Accordingly, the Reporting Person beneficially owns 1,672,500 shares of Common Stock, representing approximately 2.1% of the outstanding Common Stock. The Reporting Person has sole voting and dispositive power over such shares.